SCN8A epileptic encephalopathy: literature review and own observation

A genetic disease caused by pathogenetic nucleotide variants in the SCN8A gene (Sodium channel protein type 8 subunit alpha, also known as Nav1.6), encoding the α-subunit of the Na channel type 8, is included in the group of early epileptic encephalopathies. In most cases, this pathology is characterized by the development of polymorphic pharmacoresistant epileptic seizures over the first year of a child’s life, a lag in psychomotor development or regression, loss of skills. In some patients, seizures may appear during the first days of life, while in others they appear later (at the age of 2 to 7 months), against the background of a pronounced or slight developmental delay. Types of seizures may include generalized, tonic-clonic seizures, infantile spasms, absences and focal seizures. Other signs and symptoms of encephalopathy caused by mutations of the SCN8A gene may include low muscle tone (hypotension), high pain threshold, motor disorders (such as dystonia and ataxia), mild to severe mental retardation, sleep problems and autistic traits. In some people with SCN8A encephalopathy, various other pathological changes in the body have been reported, including hearing or vision impairment, scoliosis, and thermoregulation difficulties. The disease is inherited by an autosomal dominant type.

To date, the disease in the OMIM system is referred to as «Developmental encephalopathy and epileptic encephalopathy type 13». Previously, the disease was called «Early infantile (infantile) epileptic encephalopathy, type 13». The serial number «13» indicates this form of early epileptic encephalopathy to be caused by a heterozygous mutation in the gene on the long arm of chromosome 12 in chromosome region 12q13.13.

This report also presents a clinical description of a patient suffering from early infantile epileptic encephalopathy, type 13.

Contribution:
Nikolenko D.S. — concept, text writing, text editing;
Zholudova A.A. — concept, text writing, text editing;
Globa O.V. — concept, text writing, text editing;
Kuzenkova L.M. — concept, text editing;
Savost’yanov K.V. — concept, text editing;
Buksh A.A. — concept.
All co-authors are responsible for the integrity of all parts of the manuscript and approval of its final version.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgements. The study had no sponsorship.

Received:  May 15, 2023
Accepted:  August 30, 2023
Published: October 13, 2023

1. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010; 51(4): 676–85. https://doi.org/10.1111/j.1528-1167.2010.02522.x

2. Stosser M.B., Lindy A.S., Butler E., Retterer K., Piccirillo-Stosser C.M., Richard G., et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet. Med. 2018; 20(4): 403–10. https://doi.org/10.1038/gim.2017.114

3. SCN8A Epilepsy and related disorders. Available at: https://www.scn8a.net/Publications/

4. Developmental and Epileptic Encephalopathy 13 (DEE13) MCID: DVL041, MIFTS: 50. MalaCards Human Disease Database: https://www.malacards.org/card/developmental_and_epileptic_encephalopathy_13

5. Ohba C., Kato M., Takahashi S., Lerman-Sagie T., Lev D., Terashima H., et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia. 2014; 55(7): 994–1000. https://doi.org/10.1111/epi.12668

6. OMIM: Online Mendelian Inheritance in Man, an online catalog of human genes and genetic disorders. Developmental and epileptic encephalopathy 13; DEE13. Available at: https://omim.org/entry/614558

7. Blanchard M.G., Willemsen M.H., Walker J.B., Dib-Hajj S.D., Waxman S.G., Jongmans M.C., et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. J. Med. Genet. 2015; 52(5): 330–7. https://doi.org/10.1136/jmedgenet-2014-102813

8. Dyment D.A., Tétreault M., Beaulieu C.L., Hartley T., Ferreira P., Chardon J.W., et al. Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study. Clin. Genet. 2015; 88(1): 34–40. https://doi.org/10.1111/cge.12464

9. Savostyanov K.V. Modern algorithms of genetic diagnosis of rare hereditary diseases in Russian patients: Informational materials. Scientific publication. K.V. Savostyanov. Moscow: OOO «Polygraphist and Publisher», 2022.

10. Estacion M., O’Brien J.E., Conravey A., Hammer M.F., Waxman S.G., Dib-Hajj S.D., et al. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy. Neurobiol. Dis. 2014; 69: 117–23. https://doi.org/10.1016/j.nbd.2014.05.017

11. de Kovel C.G., Meisler M.H., Brilstra E.H., van Berkestijn F.M., van ‘t Slot R., van Lieshout S., et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy Res. 2014; 108(9): 1511–8. https://doi.org/10.1016/j.eplepsyres.2014.08.020

12. Gardella E., Becker F., Møller R.S., Schubert J., Lemke J.R., Larsen L.H., et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. Ann. Neurol. 2016; 79(3): 428–36. https://doi.org/10.1002/ana.24580

13. Scheffer I.E., Berkovic S., Capovilla G., Connolly M.B., French J., Guilhoto L., et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4): 512–21. https://doi.org/10.1111/epi.13709

14. Fung L.W., Kwok S.L., Tsui K.W. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. Epilepsia. 2015; 56(8): 1319–20. https://doi.org/10.1111/epi.13016

15. Chipaux M., Villeneuve N., Sabouraud P., Desguerre I., Boddaert N., Depienne C., et al. Unusual consequences of status epilepticus in Dravet syndrome. Seizure. 2010; 19(3): 190–4. https://doi.org/10.1016/j.seizure.2010.01.007

16. Frasier C.R., Wagnon J.L., Bao Y.O., McVeigh L.G., Lopez-Santiago L.F., Meisler M.H., et al. Cardiac arrhythmia in a mouse model of sodium channel SCN8A epileptic encephalopathy. Proc. Natl. Acad. Sci. U.S.A. 2016; 113(45): 12838–43. https://doi.org/10.1073/pnas.1612746113

17. Veeramah K.R., O’Brien J.E., Meisler M.H., Cheng X., Dib-Hajj S.D., Waxman S.G., et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am. J. Hum. Genet. 2012; 90(3): 502–10. https://doi.org/10.1016/j.ajhg.2012.01.006

18. Boerma R.S., Braun K.P., van den Broek M.P., van Berkestijn F.M., Swinkels M.E., Hagebeuk E.O., et al. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. Neurotherapeutics. 2016; 13(1): 192–7. https://doi.org/10.1007/s13311-015-0372-8

19. Hammer M.F., Wagnon J.L., Mefford H.C., Meisler M.H. SCN8A-Related Epilepsy with Encephalopathy. In: Adam M.P., Everman D.B., Mirzaa G.M., eds. GeneReviews. Seattle (WA): University of Washington; 1993-2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK379665/

20. Aledo-Serrano Á., Cabal-Paz B., Gardella E., Gómez-Porro P., Martínez-Múgica O., Beltrán-Corbellini A., et al. Effect of fenfluramine on seizures and comorbidities in SCN8A-developmental and epileptic encephalopathy: A case series. Epilepsia Open. 2022; 7(3): 525–31. https://doi.org/10.1002/epi4.12623